different glp-1 agonists Comparing Ozempic, Wegovy and Other Drugs GLP-1 Receptor Agonist Market Size

The FDA approval of Eli Lilly's GLP-1 pill Foundayo comes nearly three months after Novo Nordisk's oral version of Wegovy hit the market.

The recently initiated large-sized FLOW trial investigating the effects of semaglutide on hard renal outcomes in patients with DKD will provide clarity whether GLP-1 receptor agonists may reduce the burden of DKD in addition to their other beneficial metabolic and cardiovascular effects.

The new class of weight-loss medications are hailed as game-changing wonder drugs, but just how safe and effective are they

More recent evidence is expanding their benefits to heart failure with preserved ejection fraction and clinically important renal outcomes in patients with and without diabetes

Learn how GLP-1 receptor agonists help patients with type 2 diabetes and obesity manage blood sugar, lose weight, and protect heart health.